verapamil has been researched along with Arteriosclerosis in 64 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The VHAS (Verapamil-Hypertension Atherosclerosis Study) Investigators entered 1464 patients with essential hypertension and blood pressure (BP) values > or = 160 mmHg systolic and 95 mmHg diastolic (DBP) but excluded those with a DBP > or = 115 mmHg, and those with diabetes mellitus or previous myocardial infarction or cerebrovascular episodes." | 9.08 | Vascular complications in hypertension: the VHAS study. Verapamil-Hypertension Atherosclerosis Study. ( Zanchetti, A, 1995) |
| "The Verapamil in Hypertension and Atherosclerosis Study (VHAS) is a prospective randomized study the objective of which was to compare the long-term effects of verapamil and chlorthalidone on the blood pressure, clinical safety, and the progression/regression of carotid wall lesions in members of a large population of hypertensive patients." | 9.08 | Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators. ( Dal Palù, C; Leonetti, G; Magnani, B; Pessina, A; Rosei, EA; Zanchetti, A, 1997) |
| " The present paper reports the principal results of the ultrasound substudy of the randomized, prospective, controlled, Verapamil in Hypertension and Atherosclerosis Study (VHAS)." | 9.08 | The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. ( Dal Palù, C; Leonetti, G; Magnani, B; Pessina, A; Rosei, EA; Zanchetti, A, 1998) |
| " The Verapamil in Hypertension Atherosclerosis Study is an ongoing multicentre randomised double-blind parallel group trial comparing the antihypertensive efficacy of verapamil SR 240 mg/day with that of chlorthalidone 25 mg/day in 1464 patients with essential hypertension aged 40 to 65 years." | 9.07 | Preliminary clinical experience with calcium antagonists in atherosclerosis. Verapamil in Hypertension Atherosclerosis Study Investigators. ( Dal Palù, C; Magnani, B; Zanchetti, A, 1992) |
| " The Verapamil in Hypertension Atherosclerosis Study (VHAS) is an ongoing randomized trial, comparing the antihypertensive efficacy of verapamil 240 mg SR with chlorthalidone 25 mg in 1,464 essential hypertensives aged 40-65 years." | 9.07 | Atherosclerosis and calcium antagonists: the VHAS. The Verapamil-Hypertension Atherosclerosis Study (VHAS) Investigators. ( Dal Palù, C; Magnani, B; Zanchetti, A, 1992) |
| "In the Angina Prognosis Study in Stockholm (APSIS), 809 patients with stable angina pectoris were studied prospectively during double-blind treatment with verapamil or metoprolol." | 5.09 | Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. ( Björkander, I; Eriksson, SV; Forslund, L; Held, C; Hjemdahl, P; Rehnqvist, N, 2001) |
| "The VHAS (Verapamil-Hypertension Atherosclerosis Study) Investigators entered 1464 patients with essential hypertension and blood pressure (BP) values > or = 160 mmHg systolic and 95 mmHg diastolic (DBP) but excluded those with a DBP > or = 115 mmHg, and those with diabetes mellitus or previous myocardial infarction or cerebrovascular episodes." | 5.08 | Vascular complications in hypertension: the VHAS study. Verapamil-Hypertension Atherosclerosis Study. ( Zanchetti, A, 1995) |
| "The Verapamil in Hypertension and Atherosclerosis Study (VHAS) is a prospective randomized study the objective of which was to compare the long-term effects of verapamil and chlorthalidone on the blood pressure, clinical safety, and the progression/regression of carotid wall lesions in members of a large population of hypertensive patients." | 5.08 | Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators. ( Dal Palù, C; Leonetti, G; Magnani, B; Pessina, A; Rosei, EA; Zanchetti, A, 1997) |
| " The present paper reports the principal results of the ultrasound substudy of the randomized, prospective, controlled, Verapamil in Hypertension and Atherosclerosis Study (VHAS)." | 5.08 | The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. ( Dal Palù, C; Leonetti, G; Magnani, B; Pessina, A; Rosei, EA; Zanchetti, A, 1998) |
| " The Verapamil in Hypertension Atherosclerosis Study is an ongoing multicentre randomised double-blind parallel group trial comparing the antihypertensive efficacy of verapamil SR 240 mg/day with that of chlorthalidone 25 mg/day in 1464 patients with essential hypertension aged 40 to 65 years." | 5.07 | Preliminary clinical experience with calcium antagonists in atherosclerosis. Verapamil in Hypertension Atherosclerosis Study Investigators. ( Dal Palù, C; Magnani, B; Zanchetti, A, 1992) |
| " The Verapamil in Hypertension Atherosclerosis Study (VHAS) is an ongoing randomized trial, comparing the antihypertensive efficacy of verapamil 240 mg SR with chlorthalidone 25 mg in 1,464 essential hypertensives aged 40-65 years." | 5.07 | Atherosclerosis and calcium antagonists: the VHAS. The Verapamil-Hypertension Atherosclerosis Study (VHAS) Investigators. ( Dal Palù, C; Magnani, B; Zanchetti, A, 1992) |
| " The atherogenic significance of Ca ions and arterial Ca overload was examined under the influence of nicotine, oxidatively modified low-density lipoproteins, spontaneous hypertension, and an elevated extracellular Ca concentration or vitamin D3." | 3.69 | Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations. ( Czirfuzs, A; Fleckenstein-Grün, G; Frey, M; Matyas, S; Thimm, F, 1994) |
| " Current data suggest that only early stages of coronary atheromatosis may be affected by treatment with calcium antagonists; however, optimum drug, dosage and suitable patients are yet to be defined." | 2.38 | Can the coronary atherosclerotic process be influenced by calcium antagonists? ( Cieslinski, G; Kaltenbach, M; Kober, G; Schneider, W, 1992) |
| " The higher the dosage used, the higher the regression of the atherosclerotic lesions." | 1.32 | Planimetric and histological study of the aortae in atherosclerotic chickens treated with nifedipine, verapamil and diltiazem. ( Ayala, I; Ballesta, J; Castells, MT; Fernández Pardo, J; García Pérez, B; Madrid, JF; Ortega, JV; Ortega, MR; Valdés, M, 2003) |
| "Verapamil was examined for effects on atherosclerotic manifestations in cultured human aortic intimal cells." | 1.29 | [The antiatherosclerotic effect of verapamil in a cell culture of human aortic intima]. ( Iakushkin, VV; Orekhov, AN; Tertov, VV, 1993) |
| "Verapamil was administered subcutaneously at doses of 0." | 1.28 | The antiatherogenic dose response effect of verapamil in an experimental atherosclerosis model in the rabbit. ( Edelsteinová, S; Lazarová, Z; Lojda, Z, 1991) |
| "Verapamil or diet alone was ineffective in the second 12 weeks." | 1.27 | Verapamil and diet halt progression of atherosclerosis in cholesterol fed rabbits. ( Blumlein, S; Garrett, J; Parmley, WW; Rashid, T; Sievers, RE, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (45.31) | 18.7374 |
| 1990's | 32 (50.00) | 18.2507 |
| 2000's | 3 (4.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García Pérez, B | 1 |
| Ayala, I | 1 |
| Castells, MT | 1 |
| Madrid, JF | 1 |
| Ortega, MR | 1 |
| Ortega, JV | 1 |
| Ballesta, J | 1 |
| Fernández Pardo, J | 1 |
| Valdés, M | 1 |
| Stone, KS | 1 |
| Scordo, KA | 1 |
| Beinart, C | 1 |
| Sos, TA | 1 |
| Saddekni, S | 1 |
| Weiner, MA | 1 |
| Sniderman, KW | 1 |
| Rouleau, JL | 1 |
| Parmley, WW | 7 |
| Stevens, J | 1 |
| Wikman-Coffelt, J | 1 |
| Sievers, R | 3 |
| Mahley, RW | 1 |
| Havel, RJ | 1 |
| Bertrand, ME | 1 |
| Lablanche, JM | 1 |
| Tilmant, PY | 1 |
| Thieuleux, FA | 1 |
| Blumlein, SL | 1 |
| Kidd, P | 1 |
| Barbieri, E | 1 |
| Allegri, P | 1 |
| Morlino, T | 1 |
| Vincenzi, M | 1 |
| Severi, S | 1 |
| Davies, G | 1 |
| Maseri, A | 1 |
| Marzullo, P | 1 |
| L'Abbate, A | 1 |
| Williams, DO | 1 |
| de Oliveira, JM | 1 |
| Fleckenstein-Grün, G | 3 |
| Thimm, F | 3 |
| Frey, M | 3 |
| Matyas, S | 2 |
| Leonetti, G | 3 |
| Sampieri, L | 1 |
| Bragato, R | 1 |
| Comerio, G | 1 |
| Ciulla, TA | 1 |
| Moulton, R | 1 |
| Oberoi, A | 1 |
| Miller, JW | 1 |
| Orimo, H | 1 |
| Han, SZ | 1 |
| Tabata, RE | 1 |
| Stergiopoulos, K | 1 |
| Ouchi, Y | 1 |
| Karaki, H | 1 |
| Czirfuzs, A | 1 |
| Iakushkin, VV | 1 |
| Tertov, VV | 6 |
| Orekhov, AN | 7 |
| Salerno, SM | 1 |
| Zugibe, FT | 1 |
| Zanchetti, A | 5 |
| Ustünes, L | 1 |
| Yasa, M | 1 |
| Kerry, Z | 1 |
| Ozdemir, N | 1 |
| Berkan, T | 1 |
| Erhan, Y | 1 |
| Ozer, A | 1 |
| Rosei, EA | 2 |
| Dal Palù, C | 4 |
| Magnani, B | 4 |
| Pessina, A | 2 |
| Pitt, B | 1 |
| Pivovarova, EM | 2 |
| Dongay, B | 1 |
| Dol-Gleizes, F | 1 |
| Herbert, JM | 1 |
| Kobozeva, LP | 1 |
| Klimenko, ED | 1 |
| Michunskaia, AB | 1 |
| Pozdniakov, OM | 1 |
| Held, C | 1 |
| Hjemdahl, P | 1 |
| Eriksson, SV | 1 |
| Björkander, I | 1 |
| Forslund, L | 1 |
| Rehnqvist, N | 1 |
| Shimamoto, T | 1 |
| Moriya, K | 1 |
| Kobayashi, DV | 1 |
| Takahashi, T | 1 |
| Numano, F | 1 |
| Duarte, GM | 1 |
| Ribeiro, LG | 1 |
| Coelho, W | 1 |
| Thevenard, R | 1 |
| Souza, PJ | 1 |
| Gonçalves, MA | 1 |
| Carneiro, RD | 1 |
| Luna, RL | 1 |
| Sobenin, IA | 1 |
| Yakushkin, VV | 1 |
| Kober, G | 1 |
| Schneider, W | 1 |
| Cieslinski, G | 1 |
| Kaltenbach, M | 1 |
| Edelsteinová, S | 3 |
| Bohov, P | 1 |
| Lazarová, Z | 3 |
| Inczinger, F | 1 |
| Moiseev, VS | 1 |
| Moiseev, SV | 1 |
| Lojda, Z | 2 |
| Holub, P | 1 |
| Mrázková, O | 1 |
| Pfennigsdorf, G | 1 |
| Orekhova, NM | 1 |
| Luley, C | 1 |
| Czirfusz, A | 1 |
| Fleckenstein, A | 1 |
| Lyakishev, AA | 1 |
| Van Bortel, LM | 1 |
| Van Merode, T | 1 |
| Smeets, FA | 1 |
| Böhm, RO | 1 |
| Reneman, RS | 1 |
| Zhu, BQ | 2 |
| Sievers, RE | 2 |
| Isenberg, WM | 1 |
| Smith, DL | 1 |
| Pazin-Hricková, E | 1 |
| Bózner, A | 1 |
| Simonicová, L | 1 |
| Patriková, J | 1 |
| Ishchenko, MM | 1 |
| Shkrobot, SI | 1 |
| Weiss, K | 1 |
| Fitscha, P | 1 |
| Gazsó, A | 1 |
| Gludovacz, D | 1 |
| Sinzinger, H | 1 |
| Burtsev, EM | 1 |
| Savkov, VS | 1 |
| Akopov, SE | 1 |
| Khashimov, KA | 2 |
| Gabrielyan, ES | 1 |
| Smirnov, VN | 2 |
| Rashid, T | 1 |
| Garrett, J | 1 |
| Blumlein, S | 2 |
| Mori, S | 1 |
| Ito, H | 1 |
| Yamamoto, K | 1 |
| Larach, DR | 1 |
| Zelis, R | 1 |
| Kudryashov, SS | 1 |
| Henry, PD | 1 |
| Plate, G | 1 |
| Stanson, AW | 1 |
| Hollier, LH | 1 |
| Dewanjee, MK | 1 |
| Tilton, GD | 1 |
| Buja, LM | 1 |
| Bilheimer, DW | 1 |
| Apprill, P | 1 |
| Ashton, J | 1 |
| McNatt, J | 1 |
| Kita, T | 1 |
| Willerson, JT | 1 |
| Tozzi, CA | 1 |
| Dorrell, SG | 1 |
| Merrill, GF | 1 |
| Savenkov, PM | 1 |
| Doscicin, VL | 1 |
| Zarov, EI | 1 |
| Arsakuni, RO | 1 |
| Schamroth, L | 1 |
| Votcal, BE | 1 |
| Lozinskij, LG | 1 |
| Goldberg, VA | 1 |
| Venediktova, MG | 1 |
| Gribova, OA | 1 |
| De Liperi, E | 1 |
| Coli, R | 1 |
| Brunori, F | 1 |
| Singer, MT | 1 |
| Schvacabaja, IK | 1 |
| Mjasnikov, LA | 1 |
| Metelica, VI | 1 |
| Grigorjanc, RA | 1 |
| Dubinina, LT | 1 |
12 reviews available for verapamil and Arteriosclerosis
| Article | Year |
|---|---|
Understanding the calcium channel blockers.
Topics: Action Potentials; Angina Pectoris; Animals; Arrhythmias, Cardiac; Arteriosclerosis; Calcium; Calciu | 1984 |
Effects of antianginal agents on the coronary circulation.
Topics: Angina Pectoris; Animals; Arteriosclerosis; Calcium; Collateral Circulation; Coronary Circulation; C | 1981 |
Effect of verapamil on atherosclerosis.
Topics: Animals; Arteriosclerosis; Humans; Hypertension; Prospective Studies; Retrospective Studies; Verapam | 1993 |
Diversity of calcium antagonists.
Topics: Angina Pectoris; Arteriosclerosis; Benzimidazoles; Calcium Channel Blockers; Diltiazem; Humans; Hype | 1997 |
Can the coronary atherosclerotic process be influenced by calcium antagonists?
Topics: Animals; Arteriosclerosis; Cells, Cultured; Heart; Humans; Nifedipine; Prospective Studies; Retrospe | 1992 |
[Verapamil--on the 30th anniversary of its clinical use].
Topics: Arrhythmias, Cardiac; Arteriosclerosis; History, 20th Century; Humans; Hypertension; Myocardial Isch | 1992 |
Differentiation between calcium- and cholesterol-dominated types of arteriosclerotic lesions: antiarteriosclerotic aspects of calcium antagonists.
Topics: Animals; Arteriosclerosis; Calcium; Calcium Channel Blockers; Cholesterol; Coronary Vessels; Humans; | 1991 |
Modification of experimental and clinical atherosclerosis by dietary fish oil.
Topics: Animals; Anticoagulants; Arteriosclerosis; Blood Pressure; Dietary Fats, Unsaturated; Epoprostenol; | 1990 |
Advances in calcium blocker therapy.
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Asthma; Blood Platelet Disorders; Calcium; Calcium Channel B | 1986 |
Calcium channel blockers and atherogenesis.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Calcium; Calcium Channel Blockers; Cholesterol, Dietary; | 1987 |
Modification of experimental atherosclerosis by calcium-channel blockers.
Topics: Animals; Aorta; Arteriosclerosis; Calcium; Calcium Channel Blockers; Child; Diet, Atherogenic; Dilti | 1985 |
Atherosclerosis, calcium, and calcium antagonists.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Calcinosis; Calcium; Calcium Channel Blockers; Cell Surv | 1985 |
8 trials available for verapamil and Arteriosclerosis
| Article | Year |
|---|---|
Vascular complications in hypertension: the VHAS study. Verapamil-Hypertension Atherosclerosis Study.
Topics: Adult; Aged; Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Chlorthalidone; Double-Blind | 1995 |
Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators.
Topics: Adult; Aged; Arteriosclerosis; Blood Pressure; Calcium Channel Blockers; Chlorthalidone; Double-Blin | 1997 |
The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness.
Topics: Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Arteriosclerosis; Basal Metabolism; Blood Pr | 1998 |
Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris.
Topics: Aged; Angina Pectoris; Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Coronary Artery | 2001 |
Preliminary clinical experience with calcium antagonists in atherosclerosis. Verapamil in Hypertension Atherosclerosis Study Investigators.
Topics: Adult; Aged; Arteriosclerosis; Blood Pressure; Carotid Arteries; Chlorthalidone; Delayed-Action Prep | 1992 |
Atherosclerosis and calcium antagonists: the VHAS. The Verapamil-Hypertension Atherosclerosis Study (VHAS) Investigators.
Topics: Arteriosclerosis; Calcium Channel Blockers; Carotid Arteries; Goals; Humans; Hypertension; Research | 1992 |
[The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
Topics: Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Arteriosclerosis; Bloo | 1970 |
[Clinical study of verampamil in the treatment of patients with chronic coronary insufficiency].
Topics: Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Arteriosclerosis; Corona | 1970 |
44 other studies available for verapamil and Arteriosclerosis
| Article | Year |
|---|---|
Planimetric and histological study of the aortae in atherosclerotic chickens treated with nifedipine, verapamil and diltiazem.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Calcium Channel Blockers; Chickens; Ch | 2003 |
Arterial spasm during renal angioplasty.
Topics: Adolescent; Adult; Aged; Angioplasty, Balloon; Arterial Occlusive Diseases; Arteriosclerosis; Child; | 1983 |
Verapamil suppresses atherosclerosis in cholesterol-fed rabbits.
Topics: Adenosine Triphosphatases; Administration, Oral; Animals; Aorta; Arteriosclerosis; Cholesterol, Diet | 1983 |
[Strategy of the treatment of vasospastic angina pectoris].
Topics: Adult; Amiodarone; Angina Pectoris, Variant; Arteriosclerosis; Coronary Artery Bypass; Coronary Vaso | 1983 |
Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit.
Topics: Animals; Aorta; Arteriosclerosis; Blood Pressure; Cholesterol; Cholesterol, Dietary; Heart Rate; Hyd | 1984 |
[Changes in left ventricular regional wall motion induced by Verapamil (author's transl)].
Topics: Arteriosclerosis; Calcium; Cineradiography; Coronary Disease; Heart Ventricles; Humans; Myocardial C | 1980 |
Long-term prognosis of "variant" angina with medical treatment.
Topics: Adult; Aged; Angina Pectoris; Angina Pectoris, Variant; Arrhythmias, Cardiac; Arteriosclerosis; Coro | 1980 |
[Antihypertensive effect of verapamil in patients with and without arteriolar sclerosis at ophthalmologic examination].
Topics: Arteriosclerosis; Blood Pressure; Diuretics; Female; Heart Rate; Humans; Hypertension; Male; Ophthal | 1981 |
Progression and regression by verapamil of vitamin D3-induced calcific medial degeneration in coronary arteries of rats.
Topics: Animals; Arteriosclerosis; Calcinosis; Calcium; Calcium Channel Blockers; Cholecalciferol; Coronary | 1995 |
Retinal artery occlusion in rabbit eyes using human atheroma.
Topics: Animals; Arteriosclerosis; Carotid Artery, Common; Catheterization, Peripheral; Cholesterol; Disease | 1995 |
Calcium channel blocking substances for prevention of atherosclerosis.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Arteriosclerosis; Calci | 1995 |
Experimental vasoprotection by calcium antagonists against calcium-mediated arteriosclerotic alterations.
Topics: Adult; Aged; Aged, 80 and over; Animals; Arteriosclerosis; Calcium; Calcium Channel Blockers; Cells, | 1994 |
[The antiatherosclerotic effect of verapamil in a cell culture of human aortic intima].
Topics: Aorta; Aortic Diseases; Arteriosclerosis; Cells, Cultured; Drug Evaluation, Preclinical; Humans; Tun | 1993 |
Calcium channel antagonists. What do the second-generation agents have to offer?
Topics: Arteriosclerosis; Calcium Channel Blockers; Cardiovascular Diseases; Cerebrovascular Disorders; Dihy | 1994 |
Effect of verapamil on intimal thickening and vascular reactivity in the collared carotid artery of the rabbit.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Animals; Arteriosclerosis; Calcium Channel Blockers; Carot | 1996 |
The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells.
Topics: Adult; Amlodipine; Antihypertensive Agents; Aorta; Arteriosclerosis; Cell Division; Cells, Cultured; | 1998 |
Effect of fantofarone, a new Ca2+ channel antagonist, on angioplasty-induced vasospasm in an atherosclerotic rabbit model.
Topics: Angioplasty; Animals; Arteriosclerosis; Calcium Channel Blockers; Femoral Artery; Indolizines; Male; | 1998 |
[Correction by verapamil of the disturbed neuroregulatory systems during early atherogenesis].
Topics: Adrenergic Fibers; Animals; Aorta; Arteriosclerosis; Blood Vessels; Calcium Channel Blockers; Hypoth | 2000 |
Hyperreactive arterial endothelial cells in atherogenesis. Effect of smooth muscle relaxants.
Topics: Actomyosin; Animals; Aorta; Arteriosclerosis; Biological Transport; Carbamates; Carbon; Colchicine; | 1977 |
[Action of verapamil in coronariopathic patients. Evaluation using the ergometric test].
Topics: Adult; Aged; Arteriosclerosis; Coronary Disease; Coronary Vessels; Drug Evaluation; Female; Heart Fu | 1976 |
Use of cell culture for optimisation of direct antiatherogenic therapy with verapamil.
Topics: Administration, Oral; Aorta; Arteriosclerosis; Cells, Cultured; Cholesterol; Coronary Disease; Human | 1992 |
[Comparison of the effect of nifedipine and verapamil on lipid metabolism in experimental atherosclerosis in rabbits].
Topics: Animals; Arteriosclerosis; Fatty Acids; Lipids; Male; Nifedipine; Rabbits; Verapamil | 1992 |
[The effect of verapamil and nifedipine on the development of experimental atherosclerosis in rabbits].
Topics: Animals; Aorta; Arteriosclerosis; Lipids; Male; Nifedipine; Rabbits; Verapamil | 1992 |
[Isoptin in cardiologic practice].
Topics: Arrhythmias, Cardiac; Arteriosclerosis; Dose-Response Relationship, Drug; Drug Evaluation; Drug Moni | 1992 |
Proliferative and synthetic activity of cells from reoccluded distal anastomosis and pharmacological therapy of this postoperative complication.
Topics: 1-Methyl-3-isobutylxanthine; Anastomosis, Surgical; Aorta; Arteriosclerosis; Cell Division; Colforsi | 1991 |
Use of cultured atherosclerotic cells for investigation of antiatherosclerotic effects of anipamil and other calcium antagonists.
Topics: Aorta; Arteriosclerosis; Calcium Channel Blockers; Cell Division; Cells, Cultured; Cholesterol; Endo | 1991 |
The antiatherogenic dose response effect of verapamil in an experimental atherosclerosis model in the rabbit.
Topics: Acid Phosphatase; Animals; Aorta, Thoracic; Arteriosclerosis; beta-Galactosidase; Blood Pressure; Ch | 1991 |
Antihypertensive treatment and vessel wall properties of large arteries.
Topics: Adult; Aged; Antihypertensive Agents; Arteries; Arteriosclerosis; Benzopyrans; Carotid Arteries; Eth | 1991 |
Regression of atherosclerosis in cholesterol-fed rabbits: effects of fish oil and verapamil.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol, Dietary; Diet, Atherogenic; Docosahexaenoic Acids; Ei | 1990 |
[The effect of verapamil on experimental atherosclerosis in rabbits].
Topics: Animals; Arteriosclerosis; Blood Vessels; Heart; Male; Myocardium; Rabbits; Verapamil | 1990 |
In vitro models of anti-atherosclerotic effects of cardiovascular drugs.
Topics: Arteriosclerosis; Cell Division; Cells, Cultured; Humans; Models, Biological; Muscle, Smooth, Vascul | 1990 |
[Effect of finoptin on systemic and cerebral hemodynamics in patients with early cerebrovascular disorders in arteriosclerotic stenosis of major arteries of the head].
Topics: Adult; Aged; Arteriosclerosis; Brain Ischemia; Carotid Artery Diseases; Cerebrovascular Circulation; | 1990 |
Calcium blockers: antiatherogenic action by influencing the prostaglandin-system.
Topics: Adult; Animals; Arteriosclerosis; Calcium Channel Blockers; Diltiazem; Epoprostenol; Female; Humans; | 1989 |
[Calcium antagonists (finoptin and senzit) in the treatment of cerebrovascular disorders].
Topics: Adult; Age Factors; Arteriosclerosis; Cerebrovascular Disorders; Drug Evaluation; Fendiline; Humans; | 1989 |
Stable analogues of prostacyclin and thromboxane A2 display contradictory influences on atherosclerotic properties of cells cultured from human aorta. The effect of calcium antagonists.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aorta; Arteriosclerosis; Cells, | 1988 |
Verapamil and diet halt progression of atherosclerosis in cholesterol fed rabbits.
Topics: Animals; Arteriosclerosis; Cholesterol, Dietary; Diet; Rabbits; Verapamil | 1987 |
Effects of calcium antagonists on low density lipoprotein metabolism in human arterial smooth muscle cells.
Topics: Arteriosclerosis; Calcium Channel Blockers; Cells, Cultured; Humans; Lipoproteins, LDL; Muscle, Smoo | 1988 |
Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells.
Topics: Arteriosclerosis; Cells, Cultured; Humans; In Vitro Techniques; Muscle, Smooth, Vascular; Verapamil | 1987 |
Drug effects on platelet deposition after endothelial injury of the rabbit aorta.
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Dipyridamole; Endothelium; Epoprostenol; Ibuprofen; Plate | 1985 |
Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanabe heritable hyperlipidemic rabbit: an animal model of familial hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Disease Models, Animal; Female; Hyperlipidemias | 1985 |
Evidence of histamine-induced myocardial ischaemia: reversal by chlorpheniramine and potentiation by atherosclerosis.
Topics: Animals; Arteriosclerosis; Chlorpheniramine; Cimetidine; Coronary Circulation; Coronary Disease; Cor | 1985 |
[Verapamil in the treatment of patients with coronary insufficiency].
Topics: Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Apnea; Arteriosclerosis; Cardiac Complexes, Pr | 1970 |
Immediate effects of intravenous verapamil on atrial fibrillation.
Topics: Adult; Aged; Analysis of Variance; Arteriosclerosis; Atrial Fibrillation; Depression, Chemical; Elec | 1971 |
[Clinical trials of the effect of verapamil in subjects with angina pectoris].
Topics: Adult; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Arteriosclerosis; Coronary Disease; Female; He | 1970 |